The application of co-melt-extruded poly(ε-caprolactone) as a controlled release drug delivery device when combined with novel bioactive drug candidates: Membrane permeation and Hanson dissolution studies

Stephen J. Gardyne, Michael R. Mucalo, Michael J. Rathbone
  • Results in Pharma Sciences, May 2011, Elsevier
  • DOI: 10.1016/j.rinphs.2011.11.002

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1016/j.rinphs.2011.11.002

The following have contributed to this page: Dr Michael R Mucalo